Ieq Capital LLC Boosts Holdings in Humana Inc. $HUM

Key Points

• Ieq Capital LLC increased its stake in Humana Inc. by 916.1% during the first quarter, acquiring an additional 50,658 shares, bringing its total holdings to 56,188 shares valued at approximately $14.87 million.
• Humana announced a quarterly dividend of $0.885 per share, with an annualized yield of 1.2%, set to be paid on October 31st.
• Analysts have varied price targets for Humana, with Oppenheimer raising theirs to $310 and Bank of America reducing it to $260, reflecting a consensus rating of "Hold" with an average target price of $283.29.

Ieq Capital LLC lifted its position in Humana Inc. (NYSE:HUM - Free Report) by 916.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 56,188 shares of the insurance provider's stock after purchasing an additional 50,658 shares during the period. Ieq Capital LLC's holdings in Humana were worth $14,867,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in HUM. Revolve Wealth Partners LLC bought a new position in shares of Humana in the fourth quarter worth approximately $202,000. Northern Trust Corp grew its holdings in shares of Humana by 14.5% in the fourth quarter. Northern Trust Corp now owns 1,216,195 shares of the insurance provider's stock worth $308,561,000 after purchasing an additional 153,739 shares during the last quarter. PDT Partners LLC grew its holdings in shares of Humana by 118.7% in the fourth quarter. PDT Partners LLC now owns 8,881 shares of the insurance provider's stock worth $2,253,000 after purchasing an additional 4,821 shares during the last quarter. Triumph Capital Management grew its holdings in shares of Humana by 64.4% in the fourth quarter. Triumph Capital Management now owns 1,639 shares of the insurance provider's stock worth $416,000 after purchasing an additional 642 shares during the last quarter. Finally, Solel Partners LP bought a new position in shares of Humana in the fourth quarter worth approximately $1,116,000. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HUM. Wells Fargo & Company cut their target price on shares of Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Bank of America cut their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Robert W. Baird cut their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Finally, Barclays set a $275.00 price target on shares of Humana and gave the company an "equal weight" rating in a report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $283.29.

Humana Stock Up 2.0%

Shares of HUM stock traded up $6.01 during mid-day trading on Monday, reaching $303.90. 1,099,760 shares of the company's stock traded hands, compared to its average volume of 1,366,524. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The company has a market cap of $36.55 billion, a P/E ratio of 23.32, a P/E/G ratio of 1.79 and a beta of 0.44. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The company's 50-day moving average price is $254.43 and its 200-day moving average price is $254.59.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter last year, the firm posted $6.96 EPS. The business's quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana's payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.